电针和疼痛的门.

Same author

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

ESMO gastrointestinal oncology·2026

Same author

Quantum Spin Dynamics in Fock Space Following Quenches: Caustics and Vortices.

Physical review letters·2019

Same author

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

The European respiratory journal·2009

Same author

An electrophysiological investigation of the projection of the intramedullary primary afferent cells of the lamprey ammocoete.

Neuroscience letters·2009

Same author

Salmonella Michigan soft tissue infection in an immunocompromised child.

Journal of clinical pathology·2008

Same author

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.

Clinical genetics·2007

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

电针和疼痛的门.

相关概念视频

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

Quantum Spin Dynamics in Fock Space Following Quenches: Caustics and Vortices.

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

An electrophysiological investigation of the projection of the intramedullary primary afferent cells of the lamprey ammocoete.

Salmonella Michigan soft tissue infection in an immunocompromised child.

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

电针和疼痛的门.

相关概念视频

相关文章

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

Quantum Spin Dynamics in Fock Space Following Quenches: Caustics and Vortices.

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

An electrophysiological investigation of the projection of the intramedullary primary afferent cells of the lamprey ammocoete.

Salmonella Michigan soft tissue infection in an immunocompromised child.

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.